Stockscreener 앱 받기
97.63
0.61%
0.59
시간 외 거래:
97.49
-0.14
-0.14%
전일 마감가:
$97.04
열려 있는:
$97.35
하루 거래량:
13.27M
Relative Volume:
1.67
시가총액:
$144.66B
수익:
$18.49B
순이익/손실:
$2.50B
주가수익비율:
58.11
EPS:
1.68
순현금흐름:
$3.49B
1주 성능:
-0.06%
1개월 성능:
-7.46%
6개월 성능:
-3.22%
1년 성능:
+16.50%
1일 변동 폭
$95.84
$98.89
1주일 범위
$95.84
$100.00
52주 변동 폭
$80.64
$109.50
보스턴사이언티픽 Stock (BSX) Company Profile
명칭
Boston Scientific Corp
전화
508-683-4000
주소
300 BOSTON SCIENTIFIC WAY, MARLBOROUGH, MA
BSX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
BSX
Boston Scientific Corp
|
97.63 | 143.79B | 18.49B | 2.50B | 3.49B | 1.68 |
|
ABT
Abbott Laboratories
|
133.94 | 231.67B | 43.11B | 13.94B | 6.78B | 7.98 |
|
SYK
Stryker Corp
|
369.67 | 141.41B | 23.82B | 2.92B | 4.02B | 7.55 |
|
MDT
Medtronic Plc
|
95.24 | 120.53B | 34.20B | 4.69B | 5.30B | 3.63 |
|
EW
Edwards Lifesciences Corp
|
77.77 | 45.32B | 5.69B | 1.41B | 577.90M | 6.95 |
보스턴사이언티픽 Stock (BSX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-09-08 | 업그레이드 | Oppenheimer | Perform → Outperform |
| 2025-06-16 | 개시 | Leerink Partners | Outperform |
| 2025-04-16 | 업그레이드 | Needham | Hold → Buy |
| 2025-01-10 | 업그레이드 | Deutsche Bank | Hold → Buy |
| 2024-10-18 | 다운그레이드 | Needham | Buy → Hold |
| 2024-05-30 | 개시 | Goldman | Buy |
| 2024-02-01 | 업그레이드 | Mizuho | Neutral → Buy |
| 2023-07-19 | 개시 | Robert W. Baird | Outperform |
| 2023-06-30 | 개시 | CL King | Buy |
| 2023-05-30 | 재개 | Morgan Stanley | Overweight |
| 2023-03-29 | 개시 | UBS | Buy |
| 2022-12-22 | 개시 | Mizuho | Neutral |
| 2022-12-20 | 재개 | Citigroup | Buy |
| 2022-10-18 | 개시 | Barclays | Overweight |
| 2022-10-12 | 개시 | Jefferies | Buy |
| 2022-07-06 | 개시 | Wolfe Research | Outperform |
| 2022-05-27 | 업그레이드 | Needham | Hold → Buy |
| 2022-04-13 | 재개 | Truist | Buy |
| 2022-03-02 | 재개 | BofA Securities | Buy |
| 2021-12-10 | 개시 | RBC Capital Mkts | Outperform |
| 2021-05-26 | 다운그레이드 | Needham | Buy → Hold |
| 2021-05-25 | 개시 | Barclays | Overweight |
| 2021-04-15 | 개시 | Atlantic Equities | Overweight |
| 2020-09-17 | 개시 | Truist | Buy |
| 2020-09-11 | 개시 | Wolfe Research | Peer Perform |
| 2020-04-22 | 다운그레이드 | SVB Leerink | Outperform → Mkt Perform |
| 2020-04-01 | 업그레이드 | Goldman | Neutral → Buy |
| 2020-03-05 | 개시 | Citigroup | Buy |
| 2020-02-13 | 개시 | Goldman | Neutral |
| 2020-02-06 | 재개 | BTIG Research | Buy |
| 2019-12-30 | 재확인 | Cowen | Outperform |
| 2019-12-19 | 다운그레이드 | Needham | Strong Buy → Buy |
| 2019-09-05 | 재개 | JP Morgan | Overweight |
| 2019-09-03 | 재개 | Barclays | Overweight |
| 2019-05-13 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2018-11-28 | 개시 | UBS | Buy |
| 2018-10-16 | 개시 | Barclays | Overweight |
| 2018-10-02 | 재확인 | Morgan Stanley | Overweight |
| 2018-09-07 | 재확인 | Needham | Strong Buy |
| 2018-09-04 | 업그레이드 | Jefferies | Hold → Buy |
| 2018-07-06 | 재확인 | Needham | Strong Buy |
| 2018-06-27 | 개시 | Bernstein | Outperform |
| 2018-04-26 | 재확인 | Needham | Strong Buy |
모두보기
보스턴사이언티픽 주식(BSX)의 최신 뉴스
Boston Scientific stock price target raised to $132 at BTIG on growth outlook - Investing.com
3 Healthcare Stocks Using AI to Drive Growth - Investing.com
Union Bancaire Privee UBP SA Lowers Position in Boston Scientific Corporation $BSX - MarketBeat
Neurotech Devices Market Is Booming Worldwide 2025-2032 | Boston Scientific Corporation and BrainCo, Inc. - openPR.com
Boston Scientific stock outlook remains strong as RBC reiterates rating - Investing.com
Generate Investment Management Ltd Reduces Stock Holdings in Boston Scientific Corporation $BSX - MarketBeat
Order flow analysis tools used on Boston Scientific CorporationJuly 2025 EndofMonth & Accurate Entry/Exit Alerts - newser.com
Western Financial Corp CA Buys 9,465 Shares of Boston Scientific Corporation $BSX - MarketBeat
AAFMAA Wealth Management & Trust LLC Sells 7,118 Shares of Boston Scientific Corporation $BSX - MarketBeat
Accurate Wealth Management LLC Sells 27,611 Shares of Boston Scientific Corporation $BSX - MarketBeat
Why this $8-billion money manager likes Boston Scientific and Oracle - The Globe and Mail
November 7th Options Now Available For Boston Scientific (BSX) - Nasdaq
Piper Sandler reiterates Overweight rating on Boston Scientific stock - Investing.com
Dakota Wealth Management Purchases 5,701 Shares of Boston Scientific Corporation $BSX - MarketBeat
Fifth Third Bancorp Purchases 24,557 Shares of Boston Scientific Corporation $BSX - MarketBeat
Single-use Duodenoscope Market Forecasts and Competitive Strategies Report 2025-2033: Ambu and Boston Scientific Lead with Innovation and Infection-Free Solutions - Yahoo Finance
Boston Scientific stock price target reiterated at $115 by TD Cowen - Investing.com
Boston Scientific stock in focus as Stifel analyzes electrophysiology data ahead of investor day By Investing.com - Investing.com
Carr Financial Group Corp Invests $1.34 Million in Boston Scientific Corporation $BSX - MarketBeat
Atle Fund Management AB Sells 6,088 Shares of Boston Scientific Corporation $BSX - MarketBeat
Boston Scientific Corporation $BSX Stock Holdings Lessened by BDF Gestion - MarketBeat
Boston Scientific gains expanded CE-mark indication for Ingevity+ pacing leads to include LBBA pacing - Cardiac Rhythm News
Johnson & Johnson, Boston Scientific to Headline MEDevice Boston 2025 Keynote Sessions - Yahoo Finance
BTIG Research Reaffirms Buy Rating for Boston Scientific (NYSE:BSX) - MarketBeat
Boston Scientific Corporation $BSX Shares Sold by Pictet North America Advisors SA - MarketBeat
Exchange Traded Concepts LLC Boosts Stake in Boston Scientific Corporation $BSX - MarketBeat
Boston Scientific Corporation $BSX Shares Purchased by UMB Bank n.a. - MarketBeat
Community Trust & Investment Co. Sells 27,555 Shares of Boston Scientific Corporation $BSX - MarketBeat
Vaginal Mesh Lawsuit Settlements | September 2025 Updates - Lawsuit Information Center
Mn Services Vermogensbeheer B.V. Has $59.40 Million Stake in Boston Scientific Corporation $BSX - MarketBeat
HWG Holdings LP Has $6.46 Million Stock Holdings in Boston Scientific Corporation $BSX - MarketBeat
7,324 Shares in Boston Scientific Corporation $BSX Purchased by Thrive Wealth Management LLC - MarketBeat
Boston Scientific Corporation $BSX Shares Sold by Financiere des Professionnels Fonds d investissement inc. - MarketBeat
Boston Scientific Corporation (BSX) Expands AI-Enhanced Heart Devices With FARAPULSE Approval - Insider Monkey
Boston Scientific Corporation $BSX Holdings Boosted by Avanza Fonder AB - MarketBeat
Sowell Financial Services LLC Grows Position in Boston Scientific Corporation $BSX - MarketBeat
BTC Capital Management Inc. Takes $5.83 Million Position in Boston Scientific Corporation $BSX - MarketBeat
Czech National Bank Increases Stock Position in Boston Scientific Corporation $BSX - MarketBeat
Investors Purchase High Volume of Call Options on Boston Scientific (NYSE:BSX) - MarketBeat
Boston Scientific (NYSE:BSX) Shares Unloaded Rep. Lisa C. McClain - MarketBeat
Boston Scientific's (BSX) Buy Rating Reaffirmed at Needham & Company LLC - MarketBeat
IFM Investors Pty Ltd Purchases 19,673 Shares of Boston Scientific Corporation $BSX - MarketBeat
Channel Wealth LLC Purchases New Position in Boston Scientific Corporation $BSX - MarketBeat
Jackson Square Capital LLC Invests $6.05 Million in Boston Scientific Corporation $BSX - MarketBeat
Peak Financial Advisors LLC Invests $489,000 in Boston Scientific Corporation $BSX - MarketBeat
Kera Capital Partners Inc. Acquires New Holdings in Boston Scientific Corporation $BSX - MarketBeat
Head of Boston Scientific’s Endoscopy unit is departing - MassDevice
As biotech layoffs abound, medical device jobs are on the rise - The Business Journals
Boston Scientific Lifts Long-Term Growth Outlook Ahead Of Investor Day - Finimize
Swedbank AB Has $302.82 Million Stock Holdings in Boston Scientific Corporation $BSX - MarketBeat
Needham reiterates Buy rating on Boston Scientific stock ahead of investor day By Investing.com - Investing.com
보스턴사이언티픽 (BSX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.06%
1.35%
자본화:
|
볼륨(24시간):